Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240603585315/en/
![EVOQ® DART-TQ⁺ mass spectrometer: A high-speed, chromatography-free solution for applied markets (Photo: Business Wire)](https://mms.businesswire.com/media/20240603585315/en/2147748/4/EVOQ_DART-TQ%2B.jpg)
EVOQ® DART-TQ⁺ mass spectrometer: A high-speed, chromatography-free solution for applied markets (Photo: Business Wire)
- New EVOQ® DART-TQ+ system for chromatography-free triple-quadrupole mass spectrometry for point-of-need (PoN) routine analysis
- Launch of novel ecTOF™ with simultaneous EI and CI ionization in TOF high-resolution mass spectrometry, for ultimate confidence in compound identification with GC-HRMS
Innovative Applied Markets Solutions
The new EVOQ DART-TQ⁺mass spectrometer simplifies high-throughput testing with its integrated DART™ ion source, eliminating the need for upfront chromatography. With a 20-second analysis time per sample, it provides a fast solution for routine food and environmental testing. By bypassing traditional chromatography methods, it enhances productivity and uptime, while lowering cost of ownership. The EVOQ DART-TQ⁺also offers a quick switch-over to LC-MS mode for water and food testing with chromatography.
General Manager of
Bruker Applied Mass Spectrometry also launches the ecTOF™, a novel, compact time-of-flight mass spectrometer for high-resolution GC-HRMS that records EI and CI spectral data in a single GC run. It uniquely combines molecular ion information (via soft CI) and NIST-searchable fragment ion spectra (70 eV EI) in the same analysis in order to confidently identify unknown compounds and to reduce false positives in complex samples. The new ecTOF system also improves analysis speed, instrument uptime, and expedites post-processing. This accelerates targeted analysis of complex samples, and also represents a huge improvement in data quality for suspected and non-targeted GC-HRMS.
Dr.
About
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240603585315/en/
Media:
Head of Marketing,
Bruker Applied Mass Spectrometry
T: +1 603 809 3287
E: Meghan.Martell@bruker.com
Investor:
Sr. Director, Investor Relations & Corporate Development
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com
Source: